• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Potential HLA-matched platelet donor availability for alloimmunized patients.

作者信息

Schiffer C A, Keller C, Dutcher J P, Aisner J, Hogge D, Wiernik P H

出版信息

Transfusion. 1983 Jul-Aug;23(4):286-9. doi: 10.1046/j.1537-2995.1983.23483276859.x.

DOI:10.1046/j.1537-2995.1983.23483276859.x
PMID:6879666
Abstract

An analysis of the computer searches for HLA-matched donors was done for 100 alloimmunized patients requiring HLA-matched platelet transfusion support. With a pool of 2470 donors, an average of only 1.3 (range 0-14) perfectly matched donors were potentially available per patient. Patients had an average of 9 donors with no mismatched antigens. Although the number of potential donors increased when cross reactive or single antigen mismatches were considered, our estimate of donor availability of this type is lower than reported previously. More donors were identified for the 39 patients with relatively common genotypes than for the remaining 61 patients. Of the latter group, 25 patients did not have any potential donors with "no mismatches" while in most of the others the only suitable donor was a family member. These data suggest that, given the limitations of platelet donor selection using current HLA typing technology, it may be difficult to provide long-term platelet transfusion support for alloimmunized patients with unusual HLA types. This fact should be considered when planning intensive therapeutic regimens for alloimmunized patients with leukemia.

摘要

相似文献

1
Potential HLA-matched platelet donor availability for alloimmunized patients.
Transfusion. 1983 Jul-Aug;23(4):286-9. doi: 10.1046/j.1537-2995.1983.23483276859.x.
2
Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient.血小板交叉配型:为同种免疫性血小板减少症患者选择血小板输注的直接方法。
Am J Clin Pathol. 1988 Jul;90(1):69-72. doi: 10.1093/ajcp/90.1.69.
3
Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients.向同种免疫性血小板减少症患者成功输注与HLA抗原“不匹配”的血小板。
Am J Hematol. 1977;2(3):219-26. doi: 10.1002/ajh.2830020303.
4
Determination of an appropriate size of unrelated donor pool to be registered for HLA-matched platelet transfusion.
Transfusion. 1987 Sep-Oct;27(5):394-8. doi: 10.1046/j.1537-2995.1987.27587320531.x.
5
Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.血小板输注疗法在同种免疫患者中的应用。交叉配血程序在供体选择中的价值。
JAMA. 1982 Nov 12;248(18):2301-3.
6
Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates.通过交叉配型随机供者血小板浓缩物来选择组织相容性单采血小板供者。
Blood. 1992 Jan 15;79(2):527-31.
7
Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity.根据HLA抗体特异性为难治性患者选择血小板供体。
Transfusion. 2000 Dec;40(12):1446-56. doi: 10.1046/j.1537-2995.2000.40121446.x.
8
Platelet crossmatch testing for donor selection.用于供体选择的血小板交叉配型检测。
Prog Clin Biol Res. 1982;88:153-64.
9
Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
Zhonghua Yi Xue Za Zhi (Taipei). 1991 Apr;47(4):228-36.
10
Influence of HLA-A2 on the effectiveness of platelet transfusions in alloimmunized thrombocytopenic patients.HLA - A2对同种免疫性血小板减少症患者血小板输注效果的影响。
Blood. 1977 Sep;50(3):407-12.

引用本文的文献

1
Determination of an unrelated donor pool size for human leukocyte antigen-matched platelets in Brazil.巴西人类白细胞抗原匹配血小板无关供体库规模的确定
Rev Bras Hematol Hemoter. 2016 Jan-Feb;38(1):1-6. doi: 10.1016/j.bjhh.2015.10.005. Epub 2015 Nov 28.
2
[Alloimmunization and transfusion refractoriness to thrombocyte substitution].[血小板替代治疗中的同种免疫和输血难治性]
Klin Wochenschr. 1991 Jul 22;69(10):419-25. doi: 10.1007/BF01666826.